• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征儿童急性淋巴细胞白血病的骨髓抑制和感染并发症。

Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia.

机构信息

Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.

出版信息

Pediatr Blood Cancer. 2012 Apr;58(4):633-5. doi: 10.1002/pbc.23371. Epub 2011 Nov 21.

DOI:10.1002/pbc.23371
PMID:22106003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3279631/
Abstract

Children with Down syndrome (DS) bear an increased risk of acute lymphoblastic leukemia (ALL) and treatment complications. We compared blood counts and toxicities in 22 DS and 44 non-DS ALL patients. Patients with DS had deeper, longer neutrophil and monocyte count nadirs; more toxicities (HR 2.0, P = 0.0005); longer hospitalizations (HR 1.4, P < 0.0001); and more frequent microbiologically documented infections (HR 5.7, P = 0.0019), mucositis (HR 29.0, P = 0.0006), and cellulitis (HR 3.0, P = 0.033). Severe neutropenia, monocytopenia, and increased cellulitis in DS-ALL suggest the importance of skin hygiene, vigilance and aggressive treatment of cutaneous infections.

摘要

唐氏综合征(DS)患儿患急性淋巴细胞白血病(ALL)及治疗相关并发症的风险增加。我们比较了 22 例 DS 患儿和 44 例非 DS ALL 患儿的血象和毒性反应。DS 患儿的中性粒细胞和单核细胞计数最低值更深、更低;毒性反应更多(HR 2.0,P=0.0005);住院时间更长(HR 1.4,P<0.0001);更频繁地发生微生物学证实的感染(HR 5.7,P=0.0019)、黏膜炎(HR 29.0,P=0.0006)和蜂窝织炎(HR 3.0,P=0.033)。DS-ALL 患儿中严重中性粒细胞减少症、单核细胞减少症和蜂窝织炎发生率增加表明皮肤卫生、警惕性和积极治疗皮肤感染非常重要。

相似文献

1
Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia.唐氏综合征儿童急性淋巴细胞白血病的骨髓抑制和感染并发症。
Pediatr Blood Cancer. 2012 Apr;58(4):633-5. doi: 10.1002/pbc.23371. Epub 2011 Nov 21.
2
Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.儿童急性淋巴细胞白血病中的唐氏综合征:连续四项柏林-法兰克福-明斯特试验组试验的临床特征及治疗结果
Leukemia. 1998 May;12(5):645-51. doi: 10.1038/sj.leu.2400989.
3
Clinical presentation and risk factors of serious infections in children with Down syndrome treated for acute lymphoblastic leukemia.唐氏综合征患儿急性淋巴细胞白血病治疗期间严重感染的临床表现及危险因素
Pediatr Blood Cancer. 2016 Nov;63(11):1949-53. doi: 10.1002/pbc.26127. Epub 2016 Jul 11.
4
Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.唐氏综合征患儿急性淋巴细胞白血病的结局——波兰儿科白血病和淋巴瘤研究组报告
Pediatr Hematol Oncol. 2017 May;34(4):199-205. doi: 10.1080/08880018.2017.1363837. Epub 2017 Oct 17.
5
Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.唐氏综合征儿童急性白血病治疗的神经心理学远期效应
Pediatr Blood Cancer. 2015 May;62(5):854-8. doi: 10.1002/pbc.25362. Epub 2014 Dec 24.
6
Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia.唐氏综合征合并急性淋巴细胞白血病患儿治疗依从性差。
J Pediatr Hematol Oncol. 2009 Jan;31(1):79-80. doi: 10.1097/MPH.0b013e31818b37a9.
7
Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndrome.唐氏综合征患儿急性淋巴细胞白血病的临床和生物学特征
Am J Med Genet Suppl. 1990;7:267-71. doi: 10.1002/ajmg.1320370753.
8
Down syndrome and acute lymphoblastic leukaemia.唐氏综合征与急性淋巴细胞白血病。
Br J Haematol. 2006 Dec;135(5):595-602. doi: 10.1111/j.1365-2141.2006.06337.x. Epub 2006 Oct 10.
9
Weight Gain in Pediatric Acute Lymphoblastic Leukemia Patients With Down Syndrome.唐氏综合征小儿急性淋巴细胞白血病患者的体重增加
J Pediatr Hematol Oncol. 2018 Aug;40(6):487-488. doi: 10.1097/MPH.0000000000001066.
10
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.一项关于粒细胞集落刺激因子对高危急性淋巴细胞白血病患儿疗效的随机Ⅲ期研究。柏林-法兰克福-明斯特研究小组。
Blood. 1996 Apr 15;87(8):3143-50.

引用本文的文献

1
Down syndrome-associated leukaemias: current evidence and challenges.唐氏综合征相关白血病:当前证据与挑战
Ther Adv Hematol. 2024 Jul 23;15:20406207241257901. doi: 10.1177/20406207241257901. eCollection 2024.
2
Neutropenia and Infection Prophylaxis in Childhood Cancer.儿童癌症中性粒细胞减少和感染预防。
Curr Oncol Rep. 2022 Jun;24(6):671-686. doi: 10.1007/s11912-022-01192-5. Epub 2022 Mar 1.
3
Successful Use of EPOCH-R in 2 Young Adult Patients With Burkitt Lymphoma and Acute Kidney Injury: A Case Report.EPOCH-R方案在2例患有伯基特淋巴瘤和急性肾损伤的年轻成年患者中的成功应用:病例报告

本文引用的文献

1
Distinct abnormalities in the innate immune system of children with Down syndrome.唐氏综合征患儿固有免疫系统的明显异常。
J Pediatr. 2010 May;156(5):804-9, 809.e1-809.e5. doi: 10.1016/j.jpeds.2009.12.006. Epub 2010 Feb 20.
2
Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病诱导治疗期间与感染相关结局的危险因素。
Pediatr Infect Dis J. 2009 Dec;28(12):1064-8. doi: 10.1097/INF.0b013e3181aa6eae.
3
Intrinsic defect of the immune system in children with Down syndrome: a review.
J Pediatr Hematol Oncol. 2019 Aug;41(6):498-500. doi: 10.1097/MPH.0000000000001287.
4
Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States.美国独立儿科医院中唐氏综合征合并急性淋巴细胞白血病患儿的支持性护理利用情况及治疗毒性
Br J Haematol. 2016 Aug;174(4):591-9. doi: 10.1111/bjh.14085. Epub 2016 May 10.
5
Expression level of IL-6 secreted by bone marrow stromal cells in mice with aplastic anemia.再生障碍性贫血小鼠骨髓基质细胞分泌的白细胞介素-6表达水平
ISRN Hematol. 2013 Jun 18;2013:986219. doi: 10.1155/2013/986219. Print 2013.
唐氏综合征患儿免疫系统的内在缺陷:综述
Clin Exp Immunol. 2009 May;156(2):189-93. doi: 10.1111/j.1365-2249.2009.03890.x. Epub 2009 Jan 22.
4
Malignancy in children with trisomy 21.21三体综合征患儿的恶性肿瘤
Oncologist. 2009 Feb;14(2):164-73. doi: 10.1634/theoncologist.2008-0217. Epub 2009 Jan 28.
5
Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.唐氏综合征患儿急性淋巴细胞白血病化疗的疗效与毒性
Pediatr Blood Cancer. 2009 Jan;52(1):14-9. doi: 10.1002/pbc.21737.
6
Differential in vitro cytotoxicity does not explain increased host toxicities from chemotherapy in Down syndrome acute lymphoblastic leukemia.体外细胞毒性差异并不能解释唐氏综合征急性淋巴细胞白血病化疗中宿主毒性增加的原因。
Leuk Res. 2009 Feb;33(2):336-9. doi: 10.1016/j.leukres.2008.07.011. Epub 2008 Aug 20.
7
Chlorhexidine: expanding the armamentarium for infection control and prevention.洗必泰:拓展感染控制与预防的手段
Clin Infect Dis. 2008 Jan 15;46(2):274-81. doi: 10.1086/524736.
8
Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.绝对淋巴细胞计数是急性淋巴细胞白血病和急性髓系白血病的一种新型预后指标:对风险分层及未来研究的意义。
Cancer. 2008 Jan 15;112(2):407-15. doi: 10.1002/cncr.23168.
9
Immunological patterns in young children with Down syndrome: is there a temporal trend?唐氏综合征幼儿的免疫模式:是否存在时间趋势?
Acta Paediatr. 2007 Oct;96(10):1479-82. doi: 10.1111/j.1651-2227.2007.00459.x. Epub 2007 Aug 28.
10
Down syndrome and acute lymphoblastic leukaemia.唐氏综合征与急性淋巴细胞白血病。
Br J Haematol. 2006 Dec;135(5):595-602. doi: 10.1111/j.1365-2141.2006.06337.x. Epub 2006 Oct 10.